Assessing the Use of BotulinumtoxinA for Hyperactive Urinary Tract Dysfunction a Decade After Approval

Botulinum toxin was approved by the Food and Drug Administration in 2011 for neurogenic bladder and in 2013 for idiopathic overactive bladder (OAB) [...]

Saved in:
Bibliographic Details
Main Author: Heinrich Schulte-Baukloh
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Toxins
Subjects:
n/a
Online Access:https://www.mdpi.com/2072-6651/17/7/351
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items